Skip to main content
Erschienen in: Rheumatology International 4/2020

08.02.2020 | Case Based Review

Diffuse large B-cell lymphoma involving the left sternoclavicular joint mimicking rheumatoid arthritis flare: a case-based review

verfasst von: Sang Wan Chung, Eun Hye Park, Eun Ha Kang, Yun Jong Lee, You-Jung Ha

Erschienen in: Rheumatology International | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting primarily joints and an increased risk of developing malignant lymphomas in RA has been well reported. However, primary lymphoma in a joint in RA patient is rare. We report the case of a 65-year-old man with RA suffering from pain and swelling of left sternoclavicular (SC) joint, which was not relieved by adding low-dose glucocorticoid. Magnetic resonance imaging (MRI) showed a para-osseous soft tissue swelling around the SC joint and a fracture of proximal clavicle. Histology of the soft tissue demonstrated diffuse large B-cell lymphoma and the patient subsequently underwent R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. He was successfully treated with six cycles of R-CHOP chemotherapy, with discontinuation of MTX, resulting in a complete response. We performed a literature review and identified nine cases of lymphoma which involved joints in patients with rheumatoid arthritis. This is the first described case of a primary large B-cell lymphoma involving the unilateral SC joint in a patient with RA, which was initially confused with aggravation of RA. Therefore, malignant lymphoma should be considered in the differential diagnosis when a RA patient develops monoarthritis with spontaneous fracture, even without B symptoms.
Literatur
1.
Zurück zum Zitat Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038CrossRef Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038CrossRef
2.
Zurück zum Zitat Baecklund E, Sundstrom C, Ekbom A et al (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48(6):1543–1550CrossRef Baecklund E, Sundstrom C, Ekbom A et al (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48(6):1543–1550CrossRef
4.
Zurück zum Zitat Litwic A, Sampson M, Foria V, Dennison E (2015) Diffuse large B cell lymphoma of the foot in a patients with rheumatoid arthritis. EMJ Rheumatol 2(1):84–88 Litwic A, Sampson M, Foria V, Dennison E (2015) Diffuse large B cell lymphoma of the foot in a patients with rheumatoid arthritis. EMJ Rheumatol 2(1):84–88
5.
Zurück zum Zitat Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275–282CrossRef Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275–282CrossRef
6.
Zurück zum Zitat Smith A, Crouch S, Lax S et al (2015) Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer 112(9):1575–1584CrossRef Smith A, Crouch S, Lax S et al (2015) Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer 112(9):1575–1584CrossRef
7.
Zurück zum Zitat De Cock D, Hyrich K (2018) Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. Best Pract Res Clin Rheumatol 32(6):869–886CrossRef De Cock D, Hyrich K (2018) Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management. Best Pract Res Clin Rheumatol 32(6):869–886CrossRef
8.
Zurück zum Zitat Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212CrossRef Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212CrossRef
9.
Zurück zum Zitat Adunsky A, Yaretzky A, Klajman A (1980) Malignant lymphoma presenting as sternoclavicular joint arthritis. Arthritis Rheum 23(11):1330–1331PubMed Adunsky A, Yaretzky A, Klajman A (1980) Malignant lymphoma presenting as sternoclavicular joint arthritis. Arthritis Rheum 23(11):1330–1331PubMed
10.
Zurück zum Zitat Salloum E, Cooper DL, Howe G et al (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14(6):1943–1949CrossRef Salloum E, Cooper DL, Howe G et al (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14(6):1943–1949CrossRef
11.
Zurück zum Zitat Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED (2011) Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk. Eur J Gastroenterol Hepatol 23(12):1150–1156CrossRef Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED (2011) Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk. Eur J Gastroenterol Hepatol 23(12):1150–1156CrossRef
12.
Zurück zum Zitat Mercer LK, Galloway JB, Lunt M et al (2017) Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 76(3):497–503CrossRef Mercer LK, Galloway JB, Lunt M et al (2017) Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 76(3):497–503CrossRef
13.
Zurück zum Zitat Abe A, Wakaki K, Ishikawa H, Ito S, Murasawa A (2018) A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee. Mod Rheumatol 28(3):550–554CrossRef Abe A, Wakaki K, Ishikawa H, Ito S, Murasawa A (2018) A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee. Mod Rheumatol 28(3):550–554CrossRef
14.
Zurück zum Zitat Hatano T, Ohishi M, Yoshimoto G et al (2017) Methotrexate-related lymphoproliferative disorder presenting with severe swelling of the elbow joint: a case report. JBJS Case Connect 7(3):e65CrossRef Hatano T, Ohishi M, Yoshimoto G et al (2017) Methotrexate-related lymphoproliferative disorder presenting with severe swelling of the elbow joint: a case report. JBJS Case Connect 7(3):e65CrossRef
15.
Zurück zum Zitat Visser J, Busch VJ, de Kievit-van der Heijden IM, ten Ham AM (2012) Non-Hodgkin's lymphoma of the synovium discovered in total knee arthroplasty: a case report. BMC Res Notes 5:449CrossRef Visser J, Busch VJ, de Kievit-van der Heijden IM, ten Ham AM (2012) Non-Hodgkin's lymphoma of the synovium discovered in total knee arthroplasty: a case report. BMC Res Notes 5:449CrossRef
16.
Zurück zum Zitat Chim CS, Pang YY, Ooi GC, Mok MY, Shek TW (2006) EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment. Haematologica 91(8 Suppl):Ecr31PubMed Chim CS, Pang YY, Ooi GC, Mok MY, Shek TW (2006) EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment. Haematologica 91(8 Suppl):Ecr31PubMed
17.
Zurück zum Zitat De Angelis F, Di Rocco A, Minotti C et al (2012) Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review. Leuk Res 36(9):e199–e201CrossRef De Angelis F, Di Rocco A, Minotti C et al (2012) Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review. Leuk Res 36(9):e199–e201CrossRef
18.
Zurück zum Zitat Kennedy JW, Wong LK, Kalantarian B, Turner L, Hayes CW (2006) An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review. J Hand Surg Am 31(7):1193–1196CrossRef Kennedy JW, Wong LK, Kalantarian B, Turner L, Hayes CW (2006) An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review. J Hand Surg Am 31(7):1193–1196CrossRef
19.
Zurück zum Zitat Arredondo J, Worland RL, Sinnenberg RJ Jr, Qureshi GD (1999) Non-Hodgkin's lymphoma as an unexpected diagnosis in a shoulder arthroplasty. J Arthroplast 14(1):108–111CrossRef Arredondo J, Worland RL, Sinnenberg RJ Jr, Qureshi GD (1999) Non-Hodgkin's lymphoma as an unexpected diagnosis in a shoulder arthroplasty. J Arthroplast 14(1):108–111CrossRef
Metadaten
Titel
Diffuse large B-cell lymphoma involving the left sternoclavicular joint mimicking rheumatoid arthritis flare: a case-based review
verfasst von
Sang Wan Chung
Eun Hye Park
Eun Ha Kang
Yun Jong Lee
You-Jung Ha
Publikationsdatum
08.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 4/2020
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-020-04528-1

Weitere Artikel der Ausgabe 4/2020

Rheumatology International 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.